[Do the new drugs improve prognosis of stage IV NSCLC?].
Milleron
B
B
UF d'Oncologie pulmonaire, Hôpital Tenon, 4, rue de la Chine, 75020 Paris.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis
D000970:Antineoplastic Agents